文献速递脑血管病

延长时间窗内醒后卒中与目击卒中患者血管内治疗结局比较

Outcomes of Witnessed Versus Unwitnessed Patients With Stroke After Endovascular Therapy in the Extended Time Window.
PubMed 文献 · Stroke · 2025-11-12

研究纳入2014至2022年欧美亚66家中心前循环大血管闭塞并在最后正常时间6至24小时内行血管内取栓的患者2073例,其中未目击发作1760例(84.9%),目击发作313例(15.1%)。经逆概率治疗加权后,未目击组与目击组90天改良Rankin量表位移无差异(OR 1.35,95%CI 0.82-2.20,P=0.235),未目击组功能独立或Rankin恢复至卒中前水平的复合结局更优(OR 1.53,95%CI 1.01-2.33,P=0.045),其余次要结局无差异。

要点

  • 延长时间窗内未目击大血管闭塞患者取栓后90天mRS位移与目击患者无显著差异。
  • 未目击患者功能独立或Rankin恢复至卒中前水平的复合结局优于目击患者。
  • 症状性颅内出血与死亡率在两组间无显著差异。

核心结论

  • 延长时间窗内未目击大血管闭塞患者行血管内取栓后获得良好结局的可能性至少与目击患者相同。

研究设计与样本

  • 多中心队列研究,纳入2014至2022年欧洲、北美、亚洲66家中心前循环大血管闭塞(颈内动脉、大脑中动脉M1或M2段)且在最后正常时间6至24小时内行血管内取栓的患者。
  • 共评估5098例,最终纳入2073例,其中未目击发作1760例(84.9%),目击发作313例(15.1%);排除卒中前改良Rankin量表评分>3或年龄<18岁者。
  • 按发作模式分为目击组与未目击组,采用逆概率治疗加权比较两组结局。

主要发现

  • 单变量比较中,未目击组38.8%与目击组45.7%达到功能独立(P=0.022)。
  • 未目击组死亡率为21.6%,目击组为22.0%(P=0.847);症状性颅内出血率分别为6.6%与5.8%(P=0.623)。
  • 逆概率治疗加权后,主要结局90天改良Rankin量表位移在未目击组与目击组间无差异(OR 1.35,95%CI 0.82-2.20,P=0.235)。
  • 未目击组更可能达到功能独立或Rankin恢复至卒中前水平(OR 1.53,95%CI 1.01-2.33,P=0.045)。
  • 其他次要结局在目击组与未目击组间无差异。

临床怎么用

  • 对于最后正常时间6至24小时的前循环大血管闭塞患者,不应仅因发作未被目击而排除血管内取栓。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: It remains unclear whether outcomes of patients treated with endovascular thrombectomy with large-vessel occlusion and unwitnessed onset of stroke differ from those with witnessed onset in the extended time window. METHODS: We enrolled patients with anterior circulation large-vessel occlusion (internal carotid artery, M1, or M2 segment of the middle cerebral artery) undergoing endovascular thrombectomy within 6 to 24 hours from the time last seen well, from 2014 to 2022, at 66 sites in Europe, North America, and Asia. Patients with a prestroke modified Rankin Scale score of >3 or age <18 were excluded. We categorized patients by onset mode as witnessed or unwitnessed. The primary outcome was the modified Rankin Scale shift at 90 days. Secondary outcomes were functional independence, a composite of functional independence or return of Rankin to prestroke level, symptomatic intracranial hemorrhage, mortality, and a composite of severe disability or mortality at 90 days. We applied inverse probability of treatment weighting to compare outcomes between the groups. RESULTS: Of 5098 patients assessed for eligibility, we included 2073, of whom 1760 (84.9%) had unwitnessed onset, and 313 (15.1%) were witnessed. In the univariate comparison (before inverse probability of treatment weighting), 38.8% of the unwitnessed and 45.7% of the witnessed patients achieved functional independence (P=0.022). Mortality was 21.6% among unwitnessed and 22.0% among witnessed (P=0.847), and symptomatic intracranial hemorrhage rates were 6.6% and 5.8%, respectively (P=0.623). The primary outcome (modified Rankin Scale shift) showed no difference comparing unwitnessed to witnessed patients (odds ratio, 1.35 [95% CI, 0.82-2.20]; P=0.235) in the inverse probability of treatment weighting. Unwitnessed patients were more likely to achieve functional independence or return of Rankin (1.53 [1.01-2.33]; P=0.045). Other secondary outcomes did not differ between the witnessed and unwitnessed patients. CONCLUSIONS: In the extended time window, unwitnessed patients with large-vessel occlusion undergoing endovascular thrombectomy have at least the same likelihood of favorable outcomes as witnessed patients. REGISTRATION: URL: https://www.clinicaltrials.gov; Unique identifier: NCT04096248.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Tomppo L, Martinez-Majander N, Qureshi MM, et al. Outcomes of Witnessed Versus Unwitnessed Patients With Stroke After Endovascular Therapy in the Extended Time Window. Stroke. 2025. PMID: 41221581. doi:10.1161/STROKEAHA.125.052355

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。